Crescent Biopharma Ord Shs
CBIO14.490USD
+0.520+3.72%
Close 12/10, 16:00（ET）Quotes delayed by 15 min
201.30MMarket Cap
LossP/E TTM
More Details of Company
Crescent Biopharma Ord Shs Info
Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -
Company Executives of Crescent Biopharma Ord Shs
Name
Name/Position
Position
Shareholding
Change
Mr. Bruce Johnson
Mr. Bruce Johnson
Senior Vice President, Chief Commercial Officer
Senior Vice President, Chief Commercial Officer
--
--
Mr. Chinmaya Rath
Mr. Chinmaya Rath
Senior Vice President, Chief Business Officer
Senior Vice President, Chief Business Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Bruce Johnson
Mr. Bruce Johnson
Senior Vice President, Chief Commercial Officer
Senior Vice President, Chief Commercial Officer
--
--
Mr. Chinmaya Rath
Mr. Chinmaya Rath
Senior Vice President, Chief Business Officer
Senior Vice President, Chief Business Officer
--
--
Revenue Breakdown
FY2023
FY2022
FY2021
FY2020
FY2019
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States
0.00
0.00%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: 23 hours ago
Updated: 23 hours ago
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Fairmount Funds Management LLC
19.78%
1Globe Capital, L.L.C.
10.26%
Fidelity Management & Research Company LLC
10.18%
VR Adviser, LLC
9.99%
BVF Partners L.P.
9.99%
Other
39.80%
Shareholders
Shareholders
Proportion
Fairmount Funds Management LLC
19.78%
1Globe Capital, L.L.C.
10.26%
Fidelity Management & Research Company LLC
10.18%
VR Adviser, LLC
9.99%
BVF Partners L.P.
9.99%
Other
39.80%
Shareholder Types
Shareholders
Proportion
Hedge Fund
38.39%
Investment Advisor
18.74%
Venture Capital
14.31%
Corporation
10.26%
Private Equity
5.23%
Investment Advisor/Hedge Fund
3.92%
Research Firm
1.04%
Individual Investor
0.11%
Other
8.01%
Institutional Shareholding
Updated: Tue, Dec 9
Updated: Tue, Dec 9
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
125
11.34M
81.62%
-264.45K
2025Q3
130
11.32M
81.48%
+344.37K
2025Q2
131
10.75M
77.39%
+10.23M
2025Q1
123
307.17K
47.59%
-204.60K
2024Q4
132
303.23K
47.01%
-167.56K
2024Q3
125
177.68K
27.55%
-170.88K
2024Q2
126
261.75K
40.60%
-129.02K
2024Q1
127
376.48K
58.41%
+13.40K
2023Q4
110
351.78K
54.63%
-16.53K
2023Q3
107
347.84K
54.04%
-32.47K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Fairmount Funds Management LLC
1.39M
9.99%
--
--
Sep 30, 2025
1Globe Capital, L.L.C.
896.71K
6.45%
+896.71K
--
Aug 13, 2025
Fidelity Management & Research Company LLC
1.41M
10.18%
+490.00
+0.03%
Sep 30, 2025
VR Adviser, LLC
1.39M
9.99%
--
--
Sep 30, 2025
BVF Partners L.P.
1.39M
9.99%
--
--
Sep 30, 2025
Tang Capital Management, LLC
679.82K
4.89%
+629.67K
+1255.53%
Sep 30, 2025
The Vanguard Group, Inc.
657.90K
4.74%
+657.90K
--
Sep 30, 2025
Logos Global Management LP
600.00K
4.32%
+46.31K
+8.36%
Sep 30, 2025
Boxer Capital Management, LLC
453.69K
3.27%
--
--
Sep 30, 2025
Perceptive Advisors LLC
453.69K
3.27%
--
--
Sep 30, 2025
View more
Related ETFs
Updated: Tue, Dec 9
Updated: Tue, Dec 9
Name
Proportion
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
0%
Avantis US Small Cap Equity ETF
Proportion0%
iShares Micro-Cap ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Jun 05, 2025
Merger
100→1
Date
Type
Ratio
Jun 05, 2025
Merger
100→1
FAQs
Who are the top five shareholders of Crescent Biopharma Ord Shs?
The top five shareholders of Crescent Biopharma Ord Shs are:
Fairmount Funds Management LLC holds 1.39M shares, accounting for 9.99% of the total shares.
1Globe Capital, L.L.C. holds 896.71K shares, accounting for 6.45% of the total shares.
Fidelity Management & Research Company LLC holds 1.41M shares, accounting for 10.18% of the total shares.
VR Adviser, LLC holds 1.39M shares, accounting for 9.99% of the total shares.
BVF Partners L.P. holds 1.39M shares, accounting for 9.99% of the total shares.
Fairmount Funds Management LLC holds 1.39M shares, accounting for 9.99% of the total shares.
1Globe Capital, L.L.C. holds 896.71K shares, accounting for 6.45% of the total shares.
Fidelity Management & Research Company LLC holds 1.41M shares, accounting for 10.18% of the total shares.
VR Adviser, LLC holds 1.39M shares, accounting for 9.99% of the total shares.
BVF Partners L.P. holds 1.39M shares, accounting for 9.99% of the total shares.
What are the top three shareholder types of Crescent Biopharma Ord Shs?
The top three shareholder types of Crescent Biopharma Ord Shs are:
Fairmount Funds Management LLC
1Globe Capital, L.L.C.
Fidelity Management & Research Company LLC
Fairmount Funds Management LLC
1Globe Capital, L.L.C.
Fidelity Management & Research Company LLC
How many institutions hold shares of Crescent Biopharma Ord Shs (CBIO)?
As of 2025Q4, 125 institutions hold shares of Crescent Biopharma Ord Shs, with a combined market value of approximately 11.34M, accounting for 81.62% of the total shares. Compared to 2025Q3, institutional shareholding has increased by 0.15%.
What is the biggest source of revenue for Crescent Biopharma Ord Shs?
In FY2023, the -- business generated the highest revenue for Crescent Biopharma Ord Shs, amounting to -- and accounting for --% of total revenue.
